Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Vaccine Immunol ; 24(8)2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28637804

RESUMO

Diarrhea is a common illness among travelers to resource-limited countries, the most prevalent attributable agent being enterotoxigenic Escherichia coli (ETEC). At this time, there are no vaccines licensed specifically for the prevention of ETEC-induced traveler's diarrhea (TD), and this has propelled investigation of alternative preventive methods. Colostrum, the first milk expressed after birthing, is rich in immunoglobulins and innate immune components for protection of newborns against infectious agents. Hyperimmune bovine colostrum (HBC) produced by immunization of cows during gestation (and containing high levels of specific antibodies) is a practical and effective prophylactic tool against gastrointestinal illnesses. A commercial HBC product, Travelan, is available for prevention of ETEC-induced diarrhea. Despite its demonstrated clinical efficacy, the underlying immune components and antimicrobial activity that contribute to protection remain undefined. We investigated innate and adaptive immune components of several commercial HBC products formulated to reduce the risk of ETEC-induced diarrhea, including Travelan and IMM-124E, a newer product that has broader gastrointestinal health benefits. The immune components measured included total and ETEC-specific IgG, total IgA, cytokines, growth factors, and lactoferrin. HBC products contained high levels of IgG specific for multiple ETEC antigens, including O-polysaccharide 78 and colonization factor antigen I (CFA/I) present in the administered vaccines. Antimicrobial activity was measured in vitro using novel functional assays. HBC greatly reduced ETEC motility in soft agar and exhibited bactericidal activity in the presence of complement. We have identified immune components and antimicrobial activity potentially involved in the prevention of ETEC infection by HBC in vivo.


Assuntos
Anticorpos Antibacterianos/imunologia , Colostro/imunologia , Escherichia coli Enterotoxigênica/imunologia , Proteínas de Escherichia coli/imunologia , Fatores Imunológicos/análise , Animais , Bovinos , Colostro/química , Citocinas/análise , Citocinas/imunologia , Diarreia/prevenção & controle , Enterotoxinas/imunologia , Infecções por Escherichia coli/prevenção & controle , Feminino , Proteínas de Fímbrias/imunologia , Humanos , Imunoglobulina A , Imunoglobulina G , Peptídeos e Proteínas de Sinalização Intercelular/análise , Peptídeos e Proteínas de Sinalização Intercelular/imunologia , Lactoferrina/análise , Lactoferrina/imunologia , Gravidez , Ensaios de Anticorpos Bactericidas Séricos
2.
Clin Vaccine Immunol ; 23(9): 746-56, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27413068

RESUMO

Salmonellosis remains an important cause of human disease worldwide. While there are several licensed vaccines for Salmonella enterica serovar Typhi, these vaccines are generally ineffective against other Salmonella serovars. Vaccines that target paratyphoid and nontyphoidal Salmonella serovars are very much in need. Preclinical evaluation of candidate vaccines is highly dependent on the availability of appropriate scientific tools, particularly animal models. Many different animal models exist for various Salmonella serovars, from whole-animal models to smaller models, such as those recently established in insects. Here, we discuss various mouse, rat, rabbit, calf, primate, and insect models for Salmonella infection, all of which have their place in research. However, choosing the right model is imperative in selecting the best vaccine candidates for further clinical testing. In this minireview, we summarize the various animal models that are used to assess salmonellosis, highlight some of the advantages and disadvantages of each, and discuss their value in vaccine development.


Assuntos
Modelos Animais de Doenças , Infecções por Salmonella/patologia , Infecções por Salmonella/prevenção & controle , Vacinas contra Salmonella/imunologia , Vacinas contra Salmonella/isolamento & purificação , Animais , Avaliação Pré-Clínica de Medicamentos/métodos , Insetos , Mamíferos , Primatas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA